May 13, 2026 CoC LNL Updated Management of Schizophrenia: A Focus on Long-Acting Injectable Therapy (Pharmacists)


The Premier Continuum of Care Lunch N' Learn (LNL) May 13, 2026 CE webinar will be held from 1 - 2 pm ET. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.

Updated Management of Schizophrenia: A Focus on Long-Acting Injectable Therapy

SPEAKER: Kristin Waters, PharmD, BCPS, BCPPAssociate Clinical Professor, Department of Pharmacy Practice, University of Connecticut, Storrs, CT

ACPE Universal Activity Number: 0122-0000-26-032-L01-P [0.1 CEU] [1 Contact Hr.] 

 

Date: May 13, 2026 01:00 PM - 02:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on May 13, 2026 01:10 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Requirements for CE Credit

CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.

Support

Financial support: Premier, Inc. has received no outside support for the administration of this program.

 

Wed, May 13, 2026
 

   

Objectives

  • Identify where long-acting injectable (LAI) antipsychotics fit into treatment guidelines in the management of schizophrenia
  • Explain the potential impact of LAI antipsychotics on patient outcomes
  • Describe different LAI medications currently available for the treatment of schizophrenia

Speaker(s)/Author(s)

Kristin Waters,PharmD, BCPS, BCPP
Assistant Clinical Professor, Department of Pharmacy Practice , University of Connecticut

Activity Number

0122-0000-26-032-L01-P
Date: 05/13/26
Time: 01:00 PM - 02:00 PM

CE Hours

1.00